Sofosbuvir impurity J

• CAT Number: I013099
• CAS Number: 1334513-10-8
• Molecular Formula: C₂₂H₃₀FN₄O₈P
• Molecular Weight: 528.47
• Purity: ≥95%
• Target: HCV
• Solubility: DMSO
• IUPAC Name: propan-2-yl (2S)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate
• InChI: InChI=1S/C22H30FN4O8P/c1-13(2)33-19(29)14(3)26-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)27-11-10-17(24)25-21(27)30/h5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,26,31)(H2,24,25,30)/t14-,16+,18+,20+,22+,36-/m0/s1
• InChIKey: JMTNHBQFZOWQKE-IQWMDFIBSA-N
• SMILES: C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=NC2=O)N)(C)F)O)OC3=CC=CC=C3

Sofosbuvir Impurity J（Cat No.:I013099）is a byproduct or degradation product formed during the synthesis or storage of Sofosbuvir, a nucleotide analog prodrug used to treat hepatitis C virus (HCV) infections. This impurity is critical for pharmaceutical research and quality control, as its presence must be monitored and minimized to ensure the drug’s safety, efficacy, and regulatory compliance. Studying Sofosbuvir Impurity J helps elucidate the stability profile of Sofosbuvir, supports the development of robust manufacturing processes, and ensures adherence to stringent guidelines for impurity limits in therapeutic products.